StockData
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM) stock

AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.13−0.01 (-3.75%)

Close on Nov 18, 2026Market cap $3.98MP/E –Yield –

AIM ImmunoTech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

AIM ImmunoTech's free cash flow for the twelve months ending Dec 31, 2024 was -$14.91M. For fiscal 2024 it was -$14.91M. The highest annual figure on record is -$7.54M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$14.91M–
FY2022Dec 31, 2022-$16.19M–
FY2021Dec 31, 2021-$14.01M–
FY2020Dec 31, 2020-$10.39M–
FY2019Dec 31, 2019-$9.14M–
FY2018Dec 31, 2018-$10.69M–
FY2017Dec 31, 2017-$7.96M–
FY2016Dec 31, 2016-$7.54M–
FY2015Dec 31, 2015-$16.29M–
FY2014Dec 31, 2014-$14.47M–
FY2013Dec 31, 2013-$17.80M–
FY2012Dec 31, 2012-$18.89M–
FY2011Dec 31, 2011-$11.90M–
FY2010Dec 31, 2010-$12.62M–
FY2009Dec 31, 2009-$9.63M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$3.96M–
Q4 FY2021Dec 31, 2021-$5.75M–
Q3 FY2021Sep 30, 2021-$3.47M–
Q4 FY2020Dec 31, 2020-$2.86M–
Q3 FY2020Sep 30, 2020-$2.99M–
Q2 FY2020Jun 30, 2020-$1.28M–
Q1 FY2020Mar 31, 2020-$3.26M–
Q4 FY2019Dec 31, 2019-$2.29M–
Q3 FY2019Sep 30, 2019-$2.55M–
Q2 FY2019Jun 30, 2019-$2.83M–
Q1 FY2019Mar 31, 2019-$1.47M–
Q4 FY2018Dec 31, 2018-$2.42M–
Q4 FY2017Dec 31, 2017-$760.00K–
Q3 FY2017Sep 30, 2017-$1.90M–
Q2 FY2017Jun 30, 2017-$2.31M–
Q1 FY2017Mar 31, 2017-$3.00M–
Q4 FY2016Dec 31, 2016-$2.10M–
Q3 FY2016Sep 30, 2016-$2.99M–

More AIM ImmunoTech figures

See a number that looks wrong?